The DOI matches its Crossref record; 56 of the 57 references it cites were found in a registry or an index.
Glycolytic Reprogramming in Myofibroblast Differentiation and Lung Fibrosis
Open accessAbstract
Rationale: Dysregulation of cellular metabolism has been shown to participate in several pathologic processes. However, the role of metabolic reprogramming is not well appreciated in the pathogenesis of organ fibrosis. Objectives: To determine if glycolytic reprogramming participates in the pathogenesis of lung fibrosis and assess the therapeutic potential of glycolytic inhibition in treating lung fibrosis. Methods: A cell metabolism assay was performed to determine glycolytic flux and mitochondrial respiration. Lactate levels were measured to assess glycolysis in fibroblasts and lungs. Glycolytic inhibition by genetic and pharmacologic approaches was used to demonstrate the critical role of glycolysis in lung fibrosis. Measurements and Main Results: Augmentation of glycolysis is an early and sustained event during myofibroblast differentiation, which is dependent on the increased expression of critical glycolytic enzymes, in particular, 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 (PFKFB3). Augmented glycolysis contributes to the stabilization of hypoxia-inducible factor 1-α, a master regulator of glycolytic enzymes implicated in organ fibrosis, by increasing cellular levels of tricarboxylic acid cycle intermediate succinate in lung myofibroblasts. Inhibition of glycolysis by the PFKFB3 inhibitor 3PO or genomic disruption of the PFKFB3 gene blunted the differentiation of lung fibroblasts into myofibroblasts, and attenuated profibrotic phenotypes in myofibroblasts isolated from the lungs of patients with idiopathic pulmonary fibrosis. Inhibition of glycolysis by 3PO demonstrates therapeutic benefit in bleomycin-induced and transforming growth factor-β1–induced lung fibrosis in mice. Conclusions: Our data support the novel concept of glycolytic reprogramming in the pathogenesis of lung fibrosis and provide proof-of-concept that targeting this pathway may be efficacious in treating fibrotic disorders, such as idiopathic pulmonary fibrosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Furthermore, monocytes and macrophages are capable of remarkable functional plasticity, displaying diverse phenotypes during wound healing dependent on multiple cues including the environmental niche61,62 and the temporal stage of tissue injury and repair63–66.”
From Fibrosis: from mechanisms to medicines (2020) · cites this paper as [62]
In the citing paper
“Glycolytic reprogramming has been shown to play an important role in the pathogenesis of lung fibrosis, with higher glycolytic activity detected in fibrotic areas (143).”
From Aging and Lung Disease (2020) · cites this paper as [143]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Improved vectors and genome-wide libraries for CRISPR screening
Sanjana, N. E., Shalem, O., & Zhang, F. (2014) · Nature Methods · doi:10.1038/nmeth.3047 · Cited by 5,239
Targeting Hypoxia-Inducible Factors for the Treatment of Anemia in Chronic Kidney Disease Patients
Locatelli, F., Fishbane, S. N., Block, G. A., & Macdougall, I. C. (2017) · American Journal of Nephrology · doi:10.1159/000455166 · Cited by 4,836
Myofibroblasts and mechano-regulation of connective tissue remodelling
Tomasek, J. J., Gabbiani, G., Hinz, B., Chaponnier, C., & Brown, R. A. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm809 · Cited by 4,290
Succinate is an inflammatory signal that induces IL-1β through HIF-1α
Tannahill, G. M., Curtis, A. M., Adamik, J., Palsson-McDermott, E. M., McGettrick, A. F., Goel, G., Frezza, C., Bernard, N. J., Kelly, B., Foley, N. H., et al. (2013) · Nature · doi:10.1038/nature11986 · Cited by 4,176
The Biology of Cancer: Metabolic Reprogramming Fuels Cell Growth and Proliferation
DeBerardinis, R. J., Lum, J. J., Hatzivassiliou, G., & Thompson, C. B. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2007.10.002 · Cited by 4,088
Kim, J.-W., Tchernyshyov, I., Semenza, G. L., & Dang, C. V. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.02.002 · Cited by 3,905
Otto Warburg's contributions to current concepts of cancer metabolism
Koppenol, W. H., Bounds, P. L., & Dang, C. V. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3038 · Cited by 3,427
Metabolic Reprogramming: A Cancer Hallmark Even Warburg Did Not Anticipate
Ward, P. S., & Thompson, C. B. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.02.014 · Cited by 3,233
Aerobic glycolysis: Meeting the metabolic requirements of cell proliferation
Lunt, S. Y., & Vander Heiden, M. G. (2011) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-092910-154237 · Cited by 3,057
Hinz, B., Phan, S. H., Thannickal, V. J., Galli, A., Bochaton-Piallat, M.-L., & Gabbiani, G. (2007) · The American Journal of Pathology · doi:10.2353/ajpath.2007.070112 · Cited by 2,068
Self-citation
Research works printed but not linked: 1
- Xie, 2015, Glycolytic reprogramming is required for myofibroblast differentiation and lung fibrosis [abstract], Am J Respir Crit Care Med, 191, A4922
Cited by
Sorted by citations
Items 201–300 of 585
Mitochondrial fission and bioenergetics mediate human lung fibroblast durotaxis
Guo, T., Jiang, C., Yang, S., Zhu, Y., He, C., Carter, A. B., Antony, V. B., Peng, H., & Zhou, Y. (2022) · JCI Insight · doi:10.1172/jci.insight.157348 · Cited by 35
Sikes, K. J., Li, J., Gao, S., Shen, Q., Sandy, J. D., Plaas, A., & Wang, V. M. (2018) · Connective Tissue Research · doi:10.1080/03008207.2018.1439483 · Cited by 32
Smooth Muscle Phenotype in Idiopathic Pulmonary Hypertension: Hyper-Proliferative but not Cancerous
Perros, F., Sentenac, P., Boulate, D., Manaud, G., Kotsimbos, T. C., Lecerf, F., Lamrani, L., Fadel, É., Mercier, O. M., Londoño‐Vallejo, A., et al. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20143575 · Cited by 33
The plasticity of fibroblasts: A forgotten player in the aging process
Salminen, A. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.101995 · Cited by 36
Xu, J., Li, J., Yu, Z., Rao, H., Wang, S., & Lan, H. (2017) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2017.05.015 · Cited by 32
A two-way street - cellular metabolism and myofibroblast contraction
Noom, A., Sawitzki, B., Knaus, P., & Duda, G. N. (2024) · npj Regenerative Medicine · doi:10.1038/s41536-024-00359-x · Cited by 31
Targeting iron-metabolism:a potential therapeutic strategy for pulmonary fibrosis
Sun, Y., Ren, Y., Song, L., Wang, Y.-Y., Li, T., Wu, Y., Li, L., & Yang, Z. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116270 · Cited by 32
He, M., Zhou, C., Lu, Y., Mao, L., Xi, Y., Mei, X., Wang, X. B., Zhang, L., Yu, Z., & Zhou, Z. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/5406284 · Cited by 31
You Say You Want a Resolution (of Fibrosis)
Atabai, K., Yang, C. D., & Podolsky, M. J. (2020) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2020-0182tr · Cited by 30
TGF-β1 is a regulator of the pyruvate dehydrogenase complex in fibroblasts
Smith, E. R., & Hewitson, T. D. (2020) · Scientific Reports · doi:10.1038/s41598-020-74919-8 · Cited by 30
Shi, W., Hao, J., Wu, Y., Liu, C., Shimizu, K., Li, R., & Zhang, C. (2022) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2022.174825 · Cited by 30
Wang, Z., Hao, D., Zhao, S., Zhang, Z., Zeng, Z., & Wang, X. Q. (2023) · Molecular & Cellular Proteomics · doi:10.1016/j.mcpro.2023.100641 · Cited by 32
Wang, Y., Wu, G., Yue, H., Zhou, Q. T., Zhang, L., He, L., Gu, W., Gao, R., Dong, L., Zhang, H., et al. (2024) · Journal of Advanced Research · doi:10.1016/j.jare.2024.06.017 · Cited by 30
Yamamichi, T., Shimada, Y., Masuno, R., Ohira, T., Abe, S., Yoshimura, A., & Ikeda, N. (2019) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2019.07.100 · Cited by 29
Metabolic dysfunction and inflammatory disease: the role of stromal fibroblasts
Farah, H., Young, S. P., Mauro, C., & Jones, S. W. (2020) · FEBS Journal · doi:10.1111/febs.15644 · Cited by 30
DROSHA-Dependent miRNA and AIM2 Inflammasome Activation in Idiopathic Pulmonary Fibrosis
Cho, S. J., Lee, M., Stout-Delgado, H. W., & Moon, J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21051668 · Cited by 28
Metabolic modulation during intestinal fibrosis
Bos, S., & Laukens, D. (2020) · Journal of Digestive Diseases · doi:10.1111/1751-2980.12882 · Cited by 28
Serum metabolites as biomarkers in systemic sclerosis-associated interstitial lung disease
Meier, C. F., Freiburghaus, K., Bovet, C., Gote-Schniering, J., Allanore, Y., Distler, O., Nakas, C. T., & Maurer, B. (2020) · Scientific Reports · doi:10.1038/s41598-020-78951-6 · Cited by 30
Zhang, Y., Fu, J., Li, C., Chang, Y., Li, X., Cheng, H., Qiu, Y., Shao, M., Han, Y., Feng, D., et al. (2023) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-023-04961-y · Cited by 29
Chen, Z.-T., Zhang, H., Wang, M., Wang, S., Wen, Z., Gao, Q., Wu, M., Liu, W., Xie, Y., Mai, J., et al. (2020) · Cellular Signalling · doi:10.1016/j.cellsig.2020.109708 · Cited by 29
Hypoxia-inducible factor-1: Regulatory mechanisms and drug therapy in myocardial infarction
Pan, J., Zhang, L., Li, D., Li, Y., Lu, M., Hu, Y., Sun, B., Zhang, Z., & Li, C. (2023) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2023.176277 · Cited by 27
A comprehensive retrospect on the current perspectives and future prospects of pneumoconiosis
Hou, X., Wei, Z., Jiang, X., Wei, C., Dong, L., Li, Y., Liang, R., Nie, J., Shi, Y., & Qin, X. (2025) · Frontiers in Public Health · doi:10.3389/fpubh.2024.1435840 · Cited by 27
Wang, J., & Chao, J. (2025) · Pharmaceuticals · doi:10.3390/ph18060812 · Cited by 31
Enhanced mitophagy in bronchial fibroblasts from severe asthmatic patients
Ramakrishnan, R. K., Bajbouj, K., Hachim, M. Y., Mogas, A. K., Mahboub, B. H., Olivenstein, R., Hamoudi, R., Halwani, R., & Hamid, Q. A. (2020) · PLoS ONE · doi:10.1371/journal.pone.0242695 · Cited by 27
Wu, S., Kong, X., Sun, Y. J., Dai, X., Yu, W., Chen, R., Ma, L., & Jiang, L. (2021) · Lara D. Veeken · doi:10.1093/rheumatology/keab788 · Cited by 27
Hailiwu, R., Zeng, H., Zhan, M., Pan, T. S., Yang, H. Q., & Li, P. (2023) · Phytotherapy Research · doi:10.1002/ptr.7925 · Cited by 27
Glucose metabolic reprogramming in autoimmune diseases
Jeong, H., Lee, B., Han, S. J., & Sohn, D. H. (2023) · Animal Cells and Systems · doi:10.1080/19768354.2023.2234986 · Cited by 29
Evolving Insights on Metabolism, Autophagy, and Epigenetics in Liver Myofibroblasts
Nwosu, Z. C., Alborzinia, H., Wölfl, S., Dooley, S., & Liu, Y. (2016) · Frontiers in Physiology · doi:10.3389/fphys.2016.00191 · Cited by 27
Cardiac fibrogenesis: an immuno-metabolic perspective
Hoque, M. M., Gbadegoye, J. O., Hassan, F. O., Raafat, A., & Lebeche, D. (2024) · Frontiers in Physiology · doi:10.3389/fphys.2024.1336551 · Cited by 30
Hou, T., Ma, H., Wang, H., Chen, C., Ye, J., Ahmed, A. M., & Zheng, H. (2020) · PeerJ · doi:10.7717/peerj.10603 · Cited by 26
The Nax (SCN7A) channel: an atypical regulator of tissue homeostasis and disease
Dolivo, D., Rodrigues, A. E., Sun, L. S., Li, Y., Hou, C., Galiano, R. D., Hong, S. J., & Mustoe, T. A. (2021) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-021-03854-2 · Cited by 26
Schab, A. M., Greenwade, M. M., Stock, E. C., Lomonosova, E., Cho, K., Grither, W. R., Noia, H. M., Wilke, D., Mullen, M. M., Hagemann, A. R., et al. (2023) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-23-0347 · Cited by 26
Lu, Y., Mu, M., RenChen, X., Wang, W., Zhu, Y., Zhong, M., Jiang, Y., & Tao, X. (2023) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2023.115767 · Cited by 26
Salminen, A. (2023) · Biogerontology · doi:10.1007/s10522-023-10072-9 · Cited by 27
Ζαννίκου, Μ., Barbayianni, I., Fanidis, D., Grigorakaki, T., Vlachopoulou, E., Konstantopoulos, D., Fousteri, M. I., Nikitopoulou, I., Kotanidou, Α., Kaffe, E., et al. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.2000862 · Cited by 23
Baudo, G., Wu, S., Massaro, M., Liu, H., Lee, H., Zhang, A., Hamilton, D. J., & Blanco, E. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241310913 · Cited by 25
Li, J., Yao, W., Zhang, L., Bao, L., Chen, H., Wang, D., Yue, Z., Li, Y., Zhang, M., & Hao, C. (2017) · Respiratory Research · doi:10.1186/s12931-017-0576-z · Cited by 24
Warburg effect in keloids: A unique feature different from other types of scars
Su, Z., Jiao, H., Fan, J., Liu, L., Tian, J., Gan, C., Yang, Z.-J., Zhang, T., & Chen, Y. (2021) · Burns · doi:10.1016/j.burns.2021.03.003 · Cited by 24
Liu, W., Wu, D., Li, S., Xu, J., Li, P., Jiang, A., Zhang, Y., Liu, Z., Jiang, L., Gao, X., et al. (2021) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.1c05371 · Cited by 24
E4 engages uPAR and enolase-1 and activates urokinase to exert antifibrotic effects
Sharma, S., Watanabe, T., Nishimoto, T., Takihara, T., Mlakar, L., Nguyen, X.-X., Sanderson, M., Su, Y., Chambers, R. A., & Feghali‐Bostwick, C. A. (2021) · JCI Insight · doi:10.1172/jci.insight.144935 · Cited by 25
Cantanhede, I. G., Liu, H., Liu, H., Rodriguez, V. B., Shiwen, X., Ong, V. H., Denton, C. P., Ponticos, M., Xiong, G., de Lima-Filho, J. L., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1004949 · Cited by 26
Chiarelli, N., Zoppi, N., Ritelli, M., Venturini, M., Capitanio, D., Gelfi, C., & Colombi, M. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2020.166051 · Cited by 27
Shan, B., Zhou, H., Guo, C., Liu, X., Wu, M., Zhai, R., & Chen, J. (2023) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2023.09.008 · Cited by 23
The SIRT1/Nrf2 signaling pathway mediates the anti-pulmonary fibrosis effect of liquiritigenin
Hua, Q., & Ren, L. (2024) · Chinese Medicine · doi:10.1186/s13020-024-00886-1 · Cited by 23
Shan, B., Guo, C., Zhou, H., & Chen, J. (2024) · Journal of Advanced Research · doi:10.1016/j.jare.2024.04.029 · Cited by 23
Liang, J., Cao, H., Liu, Y., Ye, B., Sun, Y., Ke, Y., He, Y., Xu, B., & Lin, J. (2021) · Arthritis Research & Therapy · doi:10.1186/s13075-021-02578-9 · Cited by 23
Nho, R. S., Rice, C., Prasad, J. M. N., Bone, H., Farkas, L., Rojas, M. M., & Horowitz, J. C. (2023) · Physiological Reports · doi:10.14814/phy2.15759 · Cited by 23
Yang, Q., Cai, Y., Ma, Q., Xiong, A., Xu, P., Zhang, Z., Xu, J., Zhou, Y., Liu, Z., Zhao, D., et al. (2024) · Science Translational Medicine · doi:10.1126/scitranslmed.adk3868 · Cited by 22
Shin, K. W. D., Atalay, V., Çetin-Atalay, R., O’Leary, E. M., Glass, M., Szafran, J. C. H., Woods, P. S., Meliton, A. Y., Shamaa, O. R., Tian, Y., et al. (2025) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00189.2024 · Cited by 23
Tian, W., Guo, H.-S., Li, C., Cao, W., Wang, X., Mo, D., Hao, X.-W., Feng, Y.-D., Sun, Y., Fan, L., et al. (2019) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2019.02.007 · Cited by 22
Tu, M., Wei, T., Jia, Y., Wang, Y., & Wu, J. (2022) · Journal of Thoracic Disease · doi:10.21037/jtd-22-886 · Cited by 22
Interleukin-11 disrupts alveolar epithelial progenitor function
Kortekaas, R. K., Geillinger‐Kästle, K. E., Borghuis, T., Belharch, K., Webster, M. J., Timens, W., Burgess, J. K., & Gosens, R. (2023) · ERJ Open Research · doi:10.1183/23120541.00679-2022 · Cited by 26
Michaeloudes, C., Bhavsar, P. K., Mumby, S. E., Chung, K. F., & Adcock, I. M. (2017) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201702-153aw · Cited by 24
CCT6A alleviates pulmonary fibrosis by inhibiting HIF-1α-mediated lactate production
Yan, P., Yang, K., Xu, M., Zhu, M., Duan, Y., Li, W., Liu, L., Liang, C., Li, Z., Pan, X., et al. (2024) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjae021 · Cited by 23
Albendazole ameliorates aerobic glycolysis in myofibroblasts to reverse pulmonary fibrosis
Zeng, C., Yue, H., Wang, C., Ju, X., Wang, T., Fu, X., Zhou, Q., Zhang, H., He, L., Yu, J., et al. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05655-0 · Cited by 21
Panagiotidis, G., Vásquez‐Pacheco, E., Chu, X., Seeger, W., Agha, E. E., Bellusci, S., & Lingampally, A. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1609509 · Cited by 22
Impaired AMPK control of alveolar epithelial cell metabolism promotes pulmonary fibrosis
Rodríguez, L. R., Alysandratos, K., Katzen, J. B., Murthy, A., Barboza, W. R., Tomer, Y., Bui, S., Perez, R. A., Petcherski, A., Minakin, K., et al. (2025) · JCI Insight · doi:10.1172/jci.insight.182578 · Cited by 24
Zhang, J., Chen, W., Du, J., Chu, L., Zhou, Z., Zhong, W., Liu, D., Huang, H., Huang, Y., Qiao, Y., et al. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.109985 · Cited by 21
Qu, Y., Zhai, R., Wang, D., Wang, Z., Hou, G., Wu, C., Tang, M., Xiao, X., Jiao, J., Ba, Y., et al. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04241-0 · Cited by 21
Targeting reprogrammed metabolism as a therapeutic approach for respiratory diseases
Gan, P. X. L., Zhang, S., & Wong, W. S. F. (2024) · Biochemical Pharmacology · doi:10.1016/j.bcp.2024.116187 · Cited by 20
He, Y., Han, Y., Zou, L., Yao, T., Zhang, Y., Lv, X., Jiang, M., Long, L., Li, M., Cheng, X., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-64844-5 · Cited by 20
Zhang, Y., Zhong, Y., Liu, W., Fanghui, Z., Zhao, Y., Zou, L., & Liu, X. (2022) · Stem Cell Research & Therapy · doi:10.1186/s13287-022-03089-3 · Cited by 20
Shi, X., Pan, Z., Cai, W., Zhang, Y., Duo, J., Liu, R., & Cai, T. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1171445 · Cited by 20
Self-citationMa, Z., Mo, R., Yang, P., Ding, Y., Zhang, H., Dong, Z. F., Chen, Y., & Tan, Q. (2023) · The FASEB Journal · doi:10.1096/fj.202300874rr · Cited by 21
Targeting metabolic abnormalities to reverse fibrosis in iatrogenic laryngotracheal stenosis
Murphy, M. K., Motz, K., Ding, D., Yin, L. X., Duvvuri, M., Feeley, M., & Hillel, A. T. (2017) · The Laryngoscope · doi:10.1002/lary.26893 · Cited by 20
Proteomics of Rat Lungs Infected by Cryptococcus gattii Reveals a Potential Warburg-like Effect
da Rosa, R. L., Berger, M., Santi, L., Driemeier, D., Terraciano, P. B., Campos, A. R., Guimarães, J. A., Vainstein, M. H., Yates, J. R., & Beys‐da‐Silva, W. O. (2019) · Journal of Proteome Research · doi:10.1021/acs.jproteome.9b00326 · Cited by 20
Hu, Y., Yang, L., Huang, L., Zeng, C., & Ren, S. (2025) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-025-05673-1 · Cited by 19
Willette, R. N., Mangrolia, P., Pondell, S. M., Lee, C. Y. W., Yoo, S., Rudoltz, M. S., Cowen, B. R., & Welsch, D. J. (2021) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.121.000811 · Cited by 20
DACT2 protects against pulmonary fibrosis via suppressing glycolysis in lung myofibroblasts
Lai, X., Huang, S., Lin, Y., Qiu, Y., Pu, L., Lin, S., Zeng, Q., Huang, W., & Wang, Z. (2022) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2022.11.324 · Cited by 20
Ding, L., Yang, Y., Wang, Z., Su, H., Li, Y., Ma, J., Bao, T., Qi, H., Song, S., Li, J., et al. (2023) · Phytomedicine · doi:10.1016/j.phymed.2023.154707 · Cited by 19
Inositol possesses antifibrotic activity and mitigates pulmonary fibrosis
Li, J.-M., Chang, W., Li, L., Yang, D. C. H., Hsu, S., Kenyon, N. J., & Chen, C. (2023) · Respiratory Research · doi:10.1186/s12931-023-02421-6 · Cited by 23
PFKFB3 in neovascular eye disease: unraveling mechanisms and exploring therapeutic strategies
Liu, P., Sun, D., Zhang, S., Chen, S., Wang, X., Li, H., & Fang, W. (2024) · Cell & Bioscience · doi:10.1186/s13578-024-01205-9 · Cited by 19
Vang, S., Helton, E. S., Guo, Y., Burpee, B., Rose, E., Easter, M., Bollenbecker, S., Hirsch, M. J., Matthews, E. L., Jones, L., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1387197 · Cited by 18
Li, H., Li, S., Ren, C., Chen, G., Li, N., Chun-xiu, W., Wang, L., Zhao, W., Ji, X., & Jin, K. (2021) · Experimental Neurology · doi:10.1016/j.expneurol.2021.113871 · Cited by 20
Lessons from Cancer Metabolism for Pulmonary Arterial Hypertension and Fibrosis
Han, S., & Chandel, N. S. (2021) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2020-0550tr · Cited by 18
Wang, L., Xu, K., Wang, N., Ding, L., Zhao, W., Wan, R., Zhao, W., Guo, X., Pan, X., Yang, J., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232214088 · Cited by 18
miR-338-3p blocks TGFβ-induced myofibroblast differentiation through the induction of PTEN
Rackow, A. R., Judge, J., Woeller, C. F., Sime, P. J., & Kottmann, R. M. (2022) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00251.2021 · Cited by 18
Extracellular Vesicles’ Role in the Pathophysiology and as Biomarkers in Cystic Fibrosis and COPD
Gioia, S. D., Daniello, V., & Conese, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms24010228 · Cited by 20
Wu, J., Li, Y., yang, Y., Chen, R., Wang, H., Xie, K., Lan, J., Guo, M., Zhang, Y., & Li, X. (2025) · Phytomedicine · doi:10.1016/j.phymed.2025.157240 · Cited by 17
Meliton, A. Y., Shin, K. W. D., Çetin-Atalay, R., Atalay, V., Tian, Y., Szafran, J. C. H., Cho, T., Sun, K. A., Woods, P. S., Shamaa, O. R., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-64320-2 · Cited by 18
Li, G., Qin, Y., Cheng, Z., Cheng, X., Wang, R., Luo, X., Zhao, Y., Zhang, D., & Li, G. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/3235250 · Cited by 17
Pierre-Louis, J., Freeberg, M. A. T., Camus, S., Toft, R., Szomju, B. B., Rosado, R. M. S., Jackson, P., Allegood, J. C., Silvey, S. G., Liu, J., et al. (2023) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00439.2022 · Cited by 17
Gao, Q., Zhang, H., Tao, J., Chen, Z.-T., Liu, C.-Y., Liu, W., Wu, M., Yin, W.-Y., Gao, G.-H., Xie, Y., et al. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.629397 · Cited by 17
RetractedMechanisms of fibrosis in iatrogenic laryngotracheal stenosis: New discoveries and novel targets
Xu, M., Hu, B., Chen, J., Wang, J., & Li, X. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115995 · Cited by 18
PTGES is involved in myofibroblast differentiation via HIF ‐1α‐dependent glycolysis pathway
Lin, M., Lee, Y., Liao, J., Chou, C., & Yang, Y. (2024) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.70157 · Cited by 17
Lineage tracing reveals the origins and dynamics of macrophages in lung injury and repair
Jin, H., Mou, J., Zhu, H., Liu, K., Zhang, M., Zhang, Z., Pflanz, S., Kasmi, K. E., Liu, Z., Ginhoux, F., et al. (2026) · Cell Discovery · doi:10.1038/s41421-025-00859-0 · Cited by 17
Methatham, T., Nagai, R., & Aizawa, K. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23084302 · Cited by 17
Yang, X., Wang, F., Chi, X., Wang, X.-M., Cong, J., Hu, Y., & Zhang, Y. (2022) · BMC Pulmonary Medicine · doi:10.1186/s12890-022-01972-6 · Cited by 16
Wang, P., Wang, Q., Yang, X., An, Y., Wang, J., Nie, F., Pan, B., Bi, H., & Qin, Z. (2023) · Plastic & Reconstructive Surgery · doi:10.1097/prs.0000000000010137 · Cited by 16
Glycolytic reprogramming underlies immune cell activation by polyethylene wear particles
Maduka, C. V., Habeeb, O. M., Kuhnert, M. M., Hakun, M., Goodman, S. B., & Contag, C. H. (2023) · Biomaterials Advances · doi:10.1016/j.bioadv.2023.213495 · Cited by 16
Yang, C., Rubin, L., Yu, X., Lazarovici, P., & Zheng, W. (2024) · Medicinal Research Reviews · doi:10.1002/med.22014 · Cited by 16
Zhao, W., Yang, S., Hu, S., Feng, Y., & Bai, B. (2025) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2025.118954 · Cited by 15
Fibroblasts as regulators of lung immunity, repair and fibrosis
Bell, P. T., & Belz, G. T. (2026) · Nature reviews. Immunology · doi:10.1038/s41577-026-01268-4 · Cited by 19
Metabolic perturbations in systemic sclerosis
O’Reilly, S. (2021) · Current Opinion in Rheumatology · doi:10.1097/bor.0000000000000824 · Cited by 15
Control of fibrosis and hypertrophic scar formation via glycolysis regulation with IR780
Meng, X., Yu, Z., Xu, W., Chai, J., Fang, S., Min, P., Chen, Y., Zhang, Y., & Zhang, Z. (2022) · Burns & Trauma · doi:10.1093/burnst/tkac015 · Cited by 16
HIF-1α mediates renal fibrosis by regulating metabolic remodeling of renal tubule epithelial cells
Liu, D., Sun, H., Li, K., Zhao, Z., Liu, Z., Zhang, G., Ge, Y., Zhang, J., Wang, D., & Leng, Y. (2022) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2022.06.008 · Cited by 16
Jain, L., Jardim, C. A., Yulo, P. R. J., Bolam, S. M., Monk, A. P., Munro, J. T., PITTO, R. P., Tamatea, J. A. U., Dalbeth, N., & Poulsen, R. C. (2023) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2023.09.013 · Cited by 15
Li, C., Wang, J., Xu, J., Pi, J., & Zheng, B. (2024) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2024.149920 · Cited by 18
Interleukin-11 drives fibroblast metabolic reprogramming in crystalline silica-induced lung fibrosis
Xie, Y., Yang, S., Xu, Y., Gu, P. H., Zhang, Y., You, X., Yin, H., Shang, B., Yao, Y., Li, W., et al. (2024) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2024.174976 · Cited by 15
Fibroblasts in heterotopic ossification: mechanisms and therapeutic targets
Li, J., Dang, Y.-M., Liu, M., Gao, L., & Lin, H. (2024) · International Journal of Biological Sciences · doi:10.7150/ijbs.102297 · Cited by 15
Metadata
- Authors
- Xie, N., Tan, Z., Banerjee, S., Cui, H., Ge, J., Liu, R.-M., Bernard, K., Thannickal, V. J., & Liu, G.
- Affiliations
- University of Alabama at Birmingham (US)
- Corresponding author
- Liu, Gang
- ORCID
- Venue
- American Journal of Respiratory and Critical Care Medicine
- Publisher
- Oxford University Press (OUP)
- Published
- 2015-12
- Volume
- 192
- Issue
- 12
- Pages
- 1462-1474
- ISSN
- 1073-449X (ISSN-L)
- 1535-4970
- PMC
- PMC4731722
- OpenAlex
- W1793883704
- Cited by
- 582
- References
- 57
- Citations by year
- 2026: 60 · 2025: 67 · 2024: 75 · 2023: 89 · 2022: 63 · 2021: 78 · 2020: 47 · 2019: 34 · 2018: 30 · 2017: 25 · 2016: 10 · 2015: 3
- FWCI
- 17.95
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- American Journal of Respiratory and Critical Care Medicine (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Heart, Lung, and Blood Institute (HL 076206, HL114470, HL-105473, R01HL105473, R01HL076206, P01HL114470)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Pulmonary Hypertension Research and Treatments
- Keywords
- glycolytic reprogramming, pulmonary fibrosis, myofibroblast differentiation, PFKFB3, 3PO, hypoxia-inducible factor-1α, succinic acid, cellular metabolism, idiopathic pulmonary fibrosis, bleomycin-induced fibrosis, TGF-β1, glycolysis inhibition, fibroblasts
- MeSH terms
- Animals, Cell Differentiation, Cells, Cultured, Disease Models, Animal, Glycolysis, Humans, Lung, Mice, Inbred C57BL, Mice, Idiopathic Pulmonary Fibrosis, Myofibroblasts
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
